Literature DB >> 307389

HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus.

P Stastny.   

Abstract

The HLA-D region in the HLA chromosomal complex is concerned with cellular interactions and regulation of the immune response. Rheumatoid arthritis (RA) has been found to be associated with one of the HLA-D antigens. In two separate studies from this laboratory it was found that HLA-Dw4 was more frequent in RA patients than in normal controls. The patients were Caucasians suffering from erosive, rheumatoid factor positive RA. Combined results of the two studies showed HLA-Dw4 to be present in 52% of the 130 patients, compared to 13% in 119 controls (P less than 10(-6). Ia antigens were determined serologically in isolated B cells. The antigen Ia4, associated with HLA-Dw4, was increased in RA patients (70%), compared to normal controls (28%). In SLE, typing was difficult because of fragility of the B cells. Preliminary results in 14 SLE patients suggested that Ia4 was also increased in this disease. It seems likely that these associations are a reflection of genetic factors related to the immune response involved in the pathogenesis of RA and perhaps also of SLE.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307389     DOI: 10.1002/art.1780210921

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

1.  From HLA association to function.

Authors:  Jeffrey C Barrett
Journal:  Nat Genet       Date:  2012-02-27       Impact factor: 38.330

Review 2.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

Review 3.  Genetic markers as therapeutic target in rheumatoid arthritis: A game changer in clinical therapy?

Authors:  A M Mohamed Thoufic Ali; S Vino
Journal:  Rheumatol Int       Date:  2016-09-16       Impact factor: 2.631

4.  Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model.

Authors:  D A Barnes; J Tse; M Kaufhold; M Owen; J Hesselgesser; R Strieter; R Horuk; H D Perez
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

5.  Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.

Authors:  M Tishler; D Caspi; E Gazit; M Yaron
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

Review 6.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

7.  Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.

Authors:  D De Juan; J M Martín-Villa; J J Gómez-Reino; J L Vicario; A Corell; J Martínez-Laso; D Benmammar; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

8.  Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man.

Authors:  A M Solinger; R Bhatnagar; J D Stobo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

9.  DNA typing of HLA-DR antigens in systemic lupus erythematosus.

Authors:  H Dunckley; P A Gatenby; S W Serjeantson
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

10.  An HLA-DRB1-coded signal transduction ligand facilitates inflammatory arthritis: a new mechanism of autoimmunity.

Authors:  Joseph Holoshitz; Ying Liu; Jiaqi Fu; Jeena Joseph; Song Ling; Alessandro Colletta; Prannda Sharma; Dana Begun; Steven Goldstein; Russell Taichman
Journal:  J Immunol       Date:  2012-11-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.